Literature DB >> 4351191

Biochemical and pharmacological aspects of Parkinsonism.

A Carlsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4351191

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


× No keyword cloud information.
  21 in total

1.  Effects of selective dopamine D1 and D2 antagonists on male rat sexual behavior.

Authors:  S Ahlenius; K Larsson
Journal:  Experientia       Date:  1990-10-15

2.  Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony.

Authors:  Kafui Dzirasa; H Westley Phillips; Tatyana D Sotnikova; Ali Salahpour; Sunil Kumar; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 3.  Milestones in research on the pathophysiology of Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong; Jorge Guridi; Jose A Obeso
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

4.  Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

5.  Enhanced suppression of a conditioned avoidance response by haloperidol but not phenoxybenzamine in rats with bilateral parafascicular lesions.

Authors:  S Ahlenius
Journal:  Exp Brain Res       Date:  1980       Impact factor: 1.972

Review 6.  Animal models of the non-motor features of Parkinson's disease.

Authors:  Kimberly McDowell; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2012-01-03       Impact factor: 5.996

Review 7.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

8.  Spinal cord stimulation restores locomotion in animal models of Parkinson's disease.

Authors:  Romulo Fuentes; Per Petersson; William B Siesser; Marc G Caron; Miguel A L Nicolelis
Journal:  Science       Date:  2009-03-20       Impact factor: 47.728

9.  The dopamine metabolite 3-methoxytyramine is a neuromodulator.

Authors:  Tatyana D Sotnikova; Jean-Martin Beaulieu; Stefano Espinoza; Bernard Masri; Xiaodong Zhang; Ali Salahpour; Larry S Barak; Marc G Caron; Raul R Gainetdinov
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

10.  Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion.

Authors:  Maria Elena Avale; Philippe Faure; Stéphanie Pons; Patricia Robledo; Thierry Deltheil; Denis J David; Alain M Gardier; Rafael Maldonado; Sylvie Granon; Jean-Pierre Changeux; Uwe Maskos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.